Revolution Medicines Inc
NASDAQ: RVMD · HEALTHCARE · BIOTECHNOLOGY
Updated 2026-06-12
Revolution Medicines Inc (RVMD) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | $15.08M | $170.59M | $220.53M | $567.40M | $737.99M | $811.93M | $2.06B | $2.56B | $2.35B |
| Cash & equivalents | $9.08M | $69.59M | $16.66M | $104.27M | $108.50M | $161.41M | $696.15M | $543.06M | $383.75M |
| Current assets | $9.44M | $85.43M | $133.98M | $454.12M | $589.77M | $660.18M | $1.88B | $2.33B | $2.08B |
| Total liabilities | $10.55M | $73.93M | $67.99M | $92.72M | $135.42M | $126.74M | $235.51M | $293.10M | $723.21M |
| Current liabilities | $7.60M | $30.55M | $43.05M | $47.18M | $60.35M | $61.98M | $143.85M | $163.91M | $290.42M |
| Long-term debt | — | — | — | — | — | — | — | — | — |
| Shareholder equity | $4.53M | $96.66M | $152.53M | $474.68M | $602.57M | $685.19M | $1.83B | $2.27B | $1.63B |
| Retained earnings | $-67.93M | $-109.72M | $-157.39M | $-265.55M | $-452.64M | $-701.34M | $-1.14B | $-1.74B | $-2.87B |
| Accounts receivable | — | $7.30M | $8.74M | $6.39M | $5.93M | $4.67M | $1.25M | $0.00 | — |
| Inventory | — | $6.60M | $1.00 | — | $-12.72M | $1.00 | $1.00 | — | — |
| Goodwill | $0.00 | $14.61M | $14.61M | $14.61M | $14.61M | $14.61M | $14.61M | $14.61M | $14.61M |
Frequently asked questions
What is Revolution Medicines Inc's revenue?
Revolution Medicines Inc's trailing twelve-month revenue is $742000.00, and consensus projects about $2.65B by 2030. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.
How much free cash flow does RVMD generate?
RVMD produced $-913.73M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.
Is RVMD's balance sheet healthy?
RVMD holds $383.75M in cash and equivalents against — in long-term debt, on $1.63B of shareholder equity. That debt is best read against the cash flow the business throws off each year.